Endothelial cell oxidative stress and signal transduction

被引:0
作者
Foncea, R [1 ]
Carvajal, C [1 ]
Almarza, C [1 ]
Leighton, F [1 ]
机构
[1] Catholic Univ Chile, Fac Ciencias Biol, Lab Citol Bioquim & Lipidos, Dept Biol Celular & Mol, Santiago, Chile
关键词
oxidative stress; signal transduction; gene expression; endothelial cell; atherosclerosis; antioxidants;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Endothelial dysfunction (ED) is an early event in atherosclerotic disease, preceding clinical manifestations and complications. Increased reactive oxygen species (ROS) have been implicated as important mechanisms that contribute to ED, and ROS's may function as intracellular messengers that modulate signaling pathways. Several intracellular signal events stimulated by ROS have been defined, including the identification of two members of the mitogen activated protein kinase family (ERK1/2 and big MAP kinase, BMK1), tyrosine kinases (Src and Syk) and different isoenzymes of PKC as redox-sensitive kinases. ROS regulation of signal transduction components include the modification in the activity of transcriptional factors such as NFkB and others that result in changes in gene expression and modifications in cellular responses. In order to understand the intracellular mechanisms induced by ROS in endothelial cells (EC), we are studying the response of human umbilical cord vein endothelial cells to increased ROS generation by different pro-atherogenic stimuli. Our results show that Homocysteine (Hcy) and oxidized LDL (oxLDL) enhance the activity and expression of oxidative stress markers, such as NFkB and heme oxygenase 1. These results suggest that these pro-atherogenic stimuli increase oxidative stress in EC, and thus explain the loss of endothelial function associated with the atherogenic process.
引用
收藏
页码:89 / 96
页数:8
相关论文
共 54 条
[1]   Reactive oxygen species as mediators of signal transduction in cardiovascular disease [J].
Abe, J ;
Berk, BC .
TRENDS IN CARDIOVASCULAR MEDICINE, 1998, 8 (02) :59-64
[2]   c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1 (BMK1) [J].
Abe, J ;
Takahashi, M ;
Ishida, M ;
Lee, JD ;
Berk, BC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (33) :20389-20394
[4]   THE EFFECT OF CHOLESTEROL-LOWERING AND ANTIOXIDANT THERAPY ON ENDOTHELIUM-DEPENDENT CORONARY VASOMOTION [J].
ANDERSON, TJ ;
MEREDITH, IT ;
YEUNG, AC ;
FREI, B ;
SELWYN, AP ;
GANZ, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (08) :488-493
[5]  
APPLEGATE LA, 1991, CANCER RES, V51, P974
[6]   Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells [J].
Ashby, DT ;
Rye, KA ;
Clay, MA ;
Vadas, MA ;
Gamble, JR ;
Barter, PJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (09) :1450-1455
[7]   Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein [J].
Augé, N ;
Escargueil-Blanc, I ;
Lajoie-Mazenc, I ;
Suc, I ;
Andrieu-Abadie, N ;
Pieraggi, MT ;
Chatelut, M ;
Thiers, JC ;
Jaffrézou, JP ;
Laurent, G ;
Levade, T ;
Nègre-Salvayre, A ;
Salvayre, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (21) :12893-12900
[8]   DIFFERENTIAL ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASES BY H2O2 AND O-2(-) IN VASCULAR SMOOTH-MUSCLE CELLS [J].
BAAS, AS ;
BERK, BC .
CIRCULATION RESEARCH, 1995, 77 (01) :29-36
[9]   ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLICATIONS IN DIABETES [J].
BAYNES, JW .
DIABETES, 1991, 40 (04) :405-412
[10]   ATHEROSCLEROSIS - BASIC MECHANISMS - OXIDATION, INFLAMMATION, AND GENETICS [J].
BERLINER, JA ;
NAVAB, M ;
FOGELMAN, AM ;
FRANK, JS ;
DEMER, LL ;
EDWARDS, PA ;
WATSON, AD ;
LUSIS, AJ .
CIRCULATION, 1995, 91 (09) :2488-2496